Hologic

Panther Fusion® Open Access™

Laboratory Developed Tests (LDTs) are an essential part of diagnostics. Patients with certain medical conditions depend on these in-house developed tests when other options are not available. Save time and increase efficiency by consolidating your LDTs and IVD assays on the fully automated, sample-to-result, Panther Fusion system using the Open Access™ functionality.
Hologic

Panther Fusion® Respiratory Assays

The Panther Fusion Respiratory assays are the premier set of assays on the Panther Fusion system. You can provide truly personalized syndromic respiratory testing with qualitative detection and differentiation of the most common respiratory viruses from a single patient sample. Each Panther Fusion Respiratory assay can be processed independently or simultaneously with other Panther Fusion and Aptima® assays.
The Panther Fusion Flu A/B/RSV, Panther Fusion Paraflu and Panther Fusion AdV/hMPV/RV assays comprise the IVD respiratory testing menu on the fully automated Panther Fusion system. Each is a multiplex, real-time PCR in vitro diagnostic test. These assays can be run on nasopharyngeal (NP) swab specimens obtained from individuals exhibiting signs and symptoms of a respiratory tract infection.1-3  Additionally, the Panther Fusion SARS-CoV-2 assay has received Emergency Use Authorization for the detection of SARS-CoV-2 from nasopharyngeal, nasal, mid-turbinate and oropharyngeal swab specimens, nasopharyngeal wash/aspirate or nasal wash, and lower respiratory tract specimens.4
Hologic

Panther® Scalable Solutions

Panther Scalable Solutions allows you to expand your testing menu while adding on flexibility, capacity and walkaway time.
Hologic

Perinatal

The Healthcare Benefits of fFN Testing

  • Timely and appropriate interventions, such as antenatal steroids and magnesium sulfate.
  • Avoidance of unnecessary hospitalizations. One study showed that the average length of stay for patients with symptoms of preterm labor was reduced from 5.2 days to just 0.6 days after fFN testing was adopted.3
  • Effective transfer of patients at high risk of imminent preterm birth to a hospital with an appropriate NICU.

Interpreting Results

Negative Result2

 
  • Approximately 80% of patients will get a negative result.
  • A negative result means that patients have a less than 1% chance of giving birth in the next two weeks.
  • A negative result can help avoid unnecessary drug treatments, bed rest and hospitalizations. This knowledge can also provide peace of mind, freeing patients to continue with current activities without unnecessarily cancelling or rescheduling plans.
  • The Rapid fFN test can be repeated as often as every 2 weeks to monitor ongoing risk.

Positive Result2

 
  • Approximately 20% of patients will get a positive result
  • A positive result means the body is "leaking" fetal fibronectin, a sign that the patient may be preparing to give birth.
  • A positive result does not necessarily mean the patient will deliver soon, but it will alert the doctor to the fact that they are at higher risk for preterm labor.
  • The Rapid fFN test can be repeated as often as every 2 weeks to monitor ongoing risk.
Loading...

Categories

Anesthesia
Cardiology
Catheters
Critical Care
Data Management
Dental
Gynaecology
Imaging
Inhaler
Lab Technologies
Nebuliser
Neonatal Care
Operation Theatre
Radiology
Surgical Imaging
Women's Health

Brands

Brands
Address: Bhive Workspace, Shri Krishna Temple Road, Indiranagar, Bangalore 560038

Phone: +91 888 454 4755

Email: support@infomeditech.com

Quick Links

Infomeditech © 2023 All Right Reserved